Investment Insights

Concerns surrounding Schwab stemmed from recent banking issues, yet it remains a solid investment choice due to its strong franchise. Meanwhile, Moderna faces a post-COVID letdown, but its mRNA technology could pave the way for future medications, making it a potential long-term investment for those willing to take a risk.